The addition of tiragolumab (MTIG7192A) to atezolizumab (Tecentriq) and chemotherapy failed to enhance progression-free survival (PFS) and total survival (OS) in contrast with...
LEXINGTON, Ky. (WKYT/Grey Information) - A College of Kentucky dancer died months after being identified with a uncommon type of most cancers, based...